Operator

Welcome to the Q3 Fiscal Year 2026 ResMed Earnings Conference Call. My name is Darryl, and I will be your operator for today's call. [Operator Instructions] Let me hand the call to Salli Schwartz, ResMed's Chief Investor Relations Officer.

Sallilyn Schwartz
Chief Investor Relations Officer

Thanks, Darryl. I want to welcome our listeners to ResMed's Third Quarter Fiscal Year 2026 Earnings Call. We are live webcasting this call, and the replay will be available on the Investor Relations section of our corporate website later today. Our earnings press release and presentation are both available online now.

During today's call, we will discuss several non-GAAP measures that we believe provide useful information for investors. This information is not intended to be considered in isolation or as a substitute for GAAP financial information. We encourage you to review the supporting schedules in today's earnings press release to reconcile these non-GAAP measures with the GAAP reported numbers.

In addition, our discussion today will include forward-looking statements, including, but not limited to, expectations about our future financial and operating performance. We make these statements based on reasonable assumptions. However, our actual